Pearl River Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$220K Sell
2023
Q4
$1.04M Buy
2023
Q3
$659K Buy
2023
Q2
$691K Sell
2023
Q1
$595K Buy
2022
Q4
$275K Sell
2022
Q3
$493K Buy
2022
Q2
$197K Sell
2022
Q1
$568K Buy
2021
Q4
$219K Buy
2021
Q1
Sell
2020
Q4
$382K Sell
2020
Q3
$644K Buy
2020
Q2
$215K Buy
2019
Q1
Sell
2018
Q4
$12K Buy